R. Gansevoort

Nephrology · 2010–2021

A researcher in the Science corpus: 19 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Nephrology — 120 citations into it

Whom R. Gansevoort trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. A. Levey
2. Josef Coresh

Papers from R. Gansevoort's perspective

Ordered by how strongly the researchers R. Gansevoort trusts endorse each paper. Same corpus, a different order for every researcher.

1. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (Kidney International)
2. Age affects outcomes in chronic kidney disease. (Journal of the American Society of Nephrology)
3. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). (Kidney International)
4. Conference
5. Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate (Annals of Internal Medicine)
6. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. (The Lancet)
7. Prevalence of chronic kidney disease in the United States. (Journal of the American Medical Association (JAMA))
8. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations
9. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
10. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). (Kidney International)

Their papers

• Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) — 1,480 citations
• SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. (2021) — 1,383 citations
• Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. (2020) — 632 citations
• World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions (2019) — 908 citations
• A catalog of genetic loci associated with kidney function from analyses of a million individuals (2019) — 744 citations
• Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. (2017) — 787 citations
• Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial. (2015) — 628 citations
• Defining the role of common variation in the genomic and biological architecture of adult human height (2014)
• Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality (2014) — 941 citations
• Cystatin C versus Creatinine in Determining Risk Based on Kidney Function (2013) — 860 citations
• Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. (2013) — 2,001 citations
• The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis (2012) — 1,018 citations
• Comparison of risk prediction using the CKD-EPI equation and the MDRD Study equation for estimated glomerular filtration rate (2012) — 950 citations
• Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (2012) — 1,445 citations
• The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (2011) — 2,281 citations
• Association of estimated glomerular filtration rate and albuminuria with mortality and end-stage renal disease: a collaborative meta-analysis of kidney disease cohorts (2011) — 750 citations
• Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes in both general and high-risk populations (2011) — 839 citations
• Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. (2011) — 1,030 citations
• Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality: a collaborative meta-analysis of general population cohorts (2010) — 3,638 citations